Genome testing funded for MM and CLL patients The 2021 federal Budget has included an announcement of $2.9 million funding for genetic testing for people with multiple myeloma and chronic lymphocytic leukaemia. The move is expected to provide genome-wide microarray testing (GWMA) for 13,500 patients. Funding was recommended by the Medicare Services Advisory Committee (MSAC) ...
News in brief: Genome testing funded for MM and CLL patients; ISBT Congress cancelled; Nutrition guidelines for cancer patients;
17 May 2021